Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 4
1985 12
1986 14
1987 13
1988 24
1989 20
1990 22
1991 16
1992 13
1993 14
1994 15
1995 14
1996 12
1997 10
1998 10
1999 12
2000 11
2001 20
2002 15
2003 7
2004 15
2005 18
2006 13
2007 11
2008 14
2009 4
2010 7
2011 2
2012 3
2013 2
2015 3
2016 3
2018 2
2019 2
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Skin immune sentinels in health and disease.
Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Nestle FO, et al. Among authors: nickoloff bj. Nat Rev Immunol. 2009 Oct;9(10):679-91. doi: 10.1038/nri2622. Epub 2009 Sep 18. Nat Rev Immunol. 2009. PMID: 19763149 Free PMC article. Review.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. Among authors: nickoloff bj. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Among authors: nickoloff bj. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Immunopathogenesis of psoriasis.
Nickoloff BJ, Qin JZ, Nestle FO. Nickoloff BJ, et al. Clin Rev Allergy Immunol. 2007 Oct;33(1-2):45-56. doi: 10.1007/s12016-007-0039-2. Clin Rev Allergy Immunol. 2007. PMID: 18094946 Review.
A 'hairy' privilege.
Paus R, Nickoloff BJ, Ito T. Paus R, et al. Among authors: nickoloff bj. Trends Immunol. 2005 Jan;26(1):32-40. doi: 10.1016/j.it.2004.09.014. Trends Immunol. 2005. PMID: 15629407 Review.
Pathophysiology of cutaneous inflammation.
Nickoloff BJ. Nickoloff BJ. Arch Dermatol Res. 1992;284 Suppl 1:S10-1. doi: 10.1007/BF00638233. Arch Dermatol Res. 1992. PMID: 1285650 Free article. Review.
Melanoma genotypes and phenotypes get personal.
Pimiento JM, Larkin EM, Smalley KS, Wiersma GL, Monks NR, Fedorenko IV, Peterson CA, Nickoloff BJ. Pimiento JM, et al. Among authors: nickoloff bj. Lab Invest. 2013 Aug;93(8):858-67. doi: 10.1038/labinvest.2013.84. Epub 2013 Jul 1. Lab Invest. 2013. PMID: 23817084 Free article. Review.
Keratinocytes as initiators of inflammation.
Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Barker JN, et al. Among authors: nickoloff bj. Lancet. 1991 Jan 26;337(8735):211-4. doi: 10.1016/0140-6736(91)92168-2. Lancet. 1991. PMID: 1670850 Free article. Review.
375 results